Literature DB >> 30075459

Evolution of HIV-1 transmitted drug resistance in Italy in the 2007-2014 period: A weighted analysis.

M Franzetti1, A De Luca2, F Ceccherini-Silberstein3, V Spagnuolo4, E Nicastri5, C Mussini6, A Antinori5, L Monno7, J Vecchiet8, I Fanti9, A d'Arminio Monforte10, C Balotta11.   

Abstract

BACKGROUND: Recent studies suggest that transmitted drug resistance (TDR) may be decreasing in latest years, likely because of the reduced frequency of acquired resistance. However, specific risk factors, geographical areas and special HIV-infected populations may be disproportionally affected by TDR.
OBJECTIVES: Correlates of TDR and time trends were evaluated from 2007 to 2014. STUDY
DESIGN: We evaluated the genotypic results of 2155 naïve patients enrolled in the I.Co.N.A cohort at 23 clinical Centers in Italy between 2007 and 2014. A weighted analysis was performed to account for the patients enrolled in the cohort in each clinical Centre at each biennium (total number of patients: 3737).
RESULTS: Overall prevalence of TDR was 10.7%. Independent predictors of TDR were sexual risk factor (OR 2.315, p = 0.020) and non-Italian geographical origin (OR 1.57, p = 0.038). The weighted prevalence of TDR was 10.5% with a stable proportion over calendar years. Generally, TDR prevalence was numerically higher, although not significantly, in clinical Centers of metropolitan areas with more than 3 millions of residents as compared to others (11.3% vs. 9.2%). The difference in TDR prevalence between these Centers decreased in more recent years.
CONCLUSIONS: A stable frequency of TDR was observed during the most recent years in Italy, with opposite and converging trends in large metropolitan areas as compared to the rest of the country, suggesting a more homogeneous spread of TDR across the country in latest years. Concerns remain for sexual route of infection and non-Italian origin, reinforcing the need for specific prevention strategies prioritizing specific populations.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Antiretroviral resistance; HIV infection; Transmitted resistance; Weighted analysis

Mesh:

Substances:

Year:  2018        PMID: 30075459     DOI: 10.1016/j.jcv.2018.07.009

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  3 in total

1.  Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late Presenters.

Authors:  Mafalda N S Miranda; Marta Pingarilho; Victor Pimentel; Maria do Rosário O Martins; Rolf Kaiser; Carole Seguin-Devaux; Roger Paredes; Maurizio Zazzi; Francesca Incardona; Ana B Abecasis
Journal:  Front Microbiol       Date:  2022-04-13       Impact factor: 5.640

2.  HIV-1 Sub-Subtype A6: Settings for Normalised Identification and Molecular Epidemiology in the Southern Federal District, Russia.

Authors:  Madita Schlösser; Vladimir V Kartashev; Visa H Mikkola; Andrey Shemshura; Sergey Saukhat; Dmitriy Kolpakov; Alexandr Suladze; Tatiana Tverdokhlebova; Katharina Hutt; Eva Heger; Elena Knops; Michael Böhm; Veronica Di Cristanziano; Rolf Kaiser; Anders Sönnerborg; Maurizio Zazzi; Marina Bobkova; Saleta Sierra
Journal:  Viruses       Date:  2020-04-22       Impact factor: 5.048

3.  Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations.

Authors:  Marta Pingarilho; Victor Pimentel; Isabel Diogo; Sandra Fernandes; Mafalda Miranda; Andrea Pineda-Pena; Pieter Libin; Kristof Theys; M Rosário O Martins; Anne-Mieke Vandamme; Ricardo Camacho; Perpétua Gomes; Ana Abecasis
Journal:  Viruses       Date:  2020-10-30       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.